- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02763020
Postprandial Glycemic Response to Polyphenol-fortified Snack Bars
December 8, 2017 updated by: United States Army Research Institute of Environmental Medicine
Consuming plant chemicals (e.g., polyphenols) may have beneficial effects on human health that, if confirmed, may warrant inclusion in combat rations.
Ration developers would like to determine whether the fortification of a high sugar food item with a polyphenol-rich freeze-dried fruit and/or a fruit extract improves blood sugar response and promotes other positive physiological changes (e.g., satiety) in a dose-response manner.
This study will test four different types of snack bar with various polyphenol doses, and compare blood response to a snack bar without polyphenols.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
High glycemic index (GI) foods generally contain simple sugars and/or highly processed and refined carbohydrates (e.g., instant oatmeal and white bread).
These foods are rapidly digested, which raises blood glucose and insulin to higher concentrations and more rapidly compared to low GI food items.
In some situations, it is advantageous to consume high glycemic response food items to promote recovery from intense exercise/work.
However, there is some suggestion that low/moderate-GI foods may better maintain glucose levels and enhance performance if consumed before and during prolonged exercise.
Further, impaired blood glucose regulation (e.g., that can occur with chronic intake of high GI foods) may stimulate the development of oxidative stress, inflammation, dyslipidemia, insulin resistance, and diabetes; and, it is associated with changes in body weight due to stimulating hunger and excessive food intake.
These negative consequences are concerning, given the prevalence of overweight/obesity and comorbidities (including metabolic syndrome) within the Department of Defense (DoD).
Polyphenols are a heterogeneous group of phytochemicals that are found in plant-based foods; and they have antioxidant and anti-inflammatory properties that may ultimately help protect against chronic diseases, such as cancer and cardiometabolic disease.
Berry polyphenols are predominantly comprised of proanthocyanidins and/or ellagitannins (collectively referred to as "tannins"); and, berries have been shown to promote glycemic control when consumed with a high-carbohydrate containing food item.
These beneficial health effects may warrant polyphenol fortification of combat rations and Garrison food items.
For example, Natick Soldier Research, Development and Engineering Center's (NSRDEC) Combat Feeding Directorate demonstrated that tannins extracted from berries effectively inhibits the activity of enzymes that metabolize starch in vitro, an underlying mechanism for slowing starch digestion in vivo.
However, whether consumption of a high GI food item containing polyphenol-rich freeze-dried fruit and/or fruit extracts improves glucose control, reduces oxidative stress, and promotes satiety in human volunteers is unknown.
In this randomized, cross-over, placebo-controlled, dose-response trial, at least 20 civilian and/or military personnel will be asked to consume one of five food items during separate trials: 1) a high glycemic snack bar (control) without any fruit ingredients; 2) a high glycemic snack bar with cranberry extract (0.5% total weight); 3) a high glycemic snack bar with cranberry extract (1% total weight); 4) a high glycemic bar with freeze-dried black raspberries (10% total weight); and, 5) a high glycemic snack bar with freeze-dried black raspberries (20% total weight).
Serial blood sampling to measure acute changes in circulating glucose, insulin, gastrointestinal hormones and biomarkers of oxidative stress and satiety will occur at baseline and for three hours after consumption of each food.
Appetite will also be assessed at an ad libitum meal after the three hour period.
The only known risks, which this study presents to participants, are those associated with venous catheter placement.
The fruit concentrates for the present study are either commercially available (black raspberry powders) or used as an ingredient to boost the phenolic content of commercial items (cranberry extract).
The results will help determine whether fortifying high glycemic food items with polyphenols may benefit the Warfighter in the ration- or Garrison-feeding environment.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Natick, Massachusetts, United States, 01760
- USARIEM
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Soldiers who are stationed with USARIEM, NSRDEC or the U.S. Army Natick Soldier Center pool of military participants, or any civilians will be invited to participate in this study.
Exclusion Criteria:
- Potential participants will be excluded from participation if they: are under the age of 18 or over the age of 39 (i.e. insulin sensitivity declines with age, hence the upper age limit of 39 years); have a pre-existing liver disease, history of alcoholism or typically consume more than 4 alcoholic beverages daily or 6 on one occasion more than once a month within the past 6 months; have impaired glucose metabolism due to diabetes, pre-diabetes, galactosemia, hereditary fructose intolerance or glycogen storage disease; have thyroid disease; have a bleeding disorder (e.g., von Willebrand Disease, hemophilia) or are being treated with medication that will impair blood clotting; have a history of GI-related conditions that may impact glucose absorption (e.g., Crohn's disease, ulcerative colitis, Celiac's disease or gluten sensitivity, bariatric surgery or gastroparesis); are taking any medications affecting carbohydrate metabolism (e.g., insulin or oral diabetes medications); and/or, have an allergy or aversion to any of the test foods.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Food bar without fruit
snack bar without fruit
|
|
|
Experimental: Food bar with cranberry extract (0.5%)
Snack bar with cranberry extract (0.5% total weight)
|
|
|
Experimental: Food bar with cranberry extract (1.0%)
Snack bar with cranberry extract (1.0% total weight)
|
|
|
Experimental: Food bar w/ dried black raspberry (10%)
Snack bar with freeze-dried black raspberry(10% total weight)
|
|
|
Experimental: Food bar w/ dried black raspberry (20%)
Snack bar with freeze-dried black raspberry (20% total weight)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
blood glucose concentrations
Time Frame: fasting and post-prandial (every 15 minutes for the first hour and every half hour for the last two hours)
|
fasting and post-prandial (every 15 minutes for the first hour and every half hour for the last two hours)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
gut hormones
Time Frame: fasting and post-prandial (every 15 minutes for the first hour and every half hour for the last two hours)
|
fasting and post-prandial (every 15 minutes for the first hour and every half hour for the last two hours)
|
|
blood concentration of phenolic acids
Time Frame: fasting, post-prandial 60 minutes, 120 minutes and 180 minutes
|
fasting, post-prandial 60 minutes, 120 minutes and 180 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Tracey J Smith, PhD, United States Army Research Institute of Environmental Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2016
Primary Completion (Actual)
October 1, 2017
Study Completion (Actual)
November 1, 2017
Study Registration Dates
First Submitted
May 3, 2016
First Submitted That Met QC Criteria
May 4, 2016
First Posted (Estimate)
May 5, 2016
Study Record Updates
Last Update Posted (Actual)
December 12, 2017
Last Update Submitted That Met QC Criteria
December 8, 2017
Last Verified
December 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 15-28-HC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Sugar Response
-
University of GuelphCompleted
-
Anderson Advanced IngredientsINQUIS Clinical Research Ltd.Completed
-
Supplement Formulators, Inc.Sigma Tau HealthScience LLC; TSI Health Sciences, Inc.CompletedEndothelial Function | Blood SugarUnited States
-
Mars WrigleyINQUIS Clinical ResearchCompletedBlood Sugar; High | Blood Sugar; LowCanada
-
Chung Shan Medical UniversityNot yet recruitingBlood Sugar | Resistant Starch | Tapioca Starch | Prebiotic FiberTaiwan
-
Rio de Janeiro State UniversityConselho Nacional de Desenvolvimento Científico e TecnológicoCompleted
-
Purdue UniversityGrain Foods FoundationRecruitingHigh Whole Grain and Low Sugar | Medium Whole Grain and Low Sugar | Low Whole Grain and Low Sugar | Low Whole Grain and High SugarUnited States
-
University of California, Los AngelesWithdrawnBlood Sugar (Glucose) Control | Blood Vessel (Vascular) DysfunctionUnited States
-
Arizona State UniversityCompletedDietary Added Sugar ConsumptionUnited States
-
University Medical Centre MariborRecruitingSepsis | Diabetes Mellitus | Blood Sugar | Critically Ill Intensive Care Unit PatientsSlovenia
Clinical Trials on placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
AkesoNot yet recruitingAtopic DermatitisChina
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of